Variant report
Variant | esv3404895 |
---|---|
Chromosome Location | chr5:117645772-117646332 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DMXL1-9 | chr5:117646168-117646321 | ucscGeneNc_uc003krz_2 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs56024021 | chr5:117645800-117645801 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs577251438 | chr5:117645842-117645843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs193095592 | chr5:117645871-117645872 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs185706493 | chr5:117645893-117645894 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188784525 | chr5:117645905-117645906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs150582979 | chr5:117645909-117645910 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs72788074 | chr5:117645917-117645918 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs139593644 | chr5:117645925-117645926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550293689 | chr5:117645953-117645954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs149716769 | chr5:117645956-117645957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532880035 | chr5:117645965-117645966 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs114966956 | chr5:117645994-117645995 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs548412883 | chr5:117646043-117646044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566288436 | chr5:117646047-117646048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535374865 | chr5:117646054-117646055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs565606351 | chr5:117646095-117646096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568788540 | chr5:117646100-117646101 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs113588927 | chr5:117646120-117646121 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147549411 | chr5:117646128-117646129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7446985 | chr5:117646132-117646133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557069483 | chr5:117646135-117646136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs145544088 | chr5:117646175-117646176 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs577270715 | chr5:117646176-117646177 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs547431989 | chr5:117646183-117646184 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs140079503 | chr5:117646186-117646187 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs573448345 | chr5:117646189-117646190 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs113054731 | chr5:117646201-117646202 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs3924812 | chr5:117646202-117646203 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs562404161 | chr5:117646234-117646235 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs143667103 | chr5:117646238-117646239 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs576001811 | chr5:117646247-117646248 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs544245226 | chr5:117646290-117646291 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs563877145 | chr5:117646311-117646312 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs183879782 | chr5:117646316-117646317 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22543975 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:117644800-117645800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr5:117644800-117645800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr5:117644800-117646000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr5:117645000-117647400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr5:117645200-117645800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr5:117645600-117645800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr5:117645800-117647400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr5:117646000-117647000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |